COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 726: Articles 7251-7260  | Next

The prevalence of SARS-CoV-2 infection and uptake of COVID-19 antiviral treatments during the BA.2/BA.2.12.1 surge, New York City, April-May 2022
Qasmieh, S., Robertson, M., Teasdale, C. A., Kulkarni, S., McNairy, M., Borrell, L. N., Nash, D.
10.1101/2022.05.25.22275603 — Posted: 2022-05-26
Motivation, intention and action: wearing masks to prevent the spread of COVID-19
Kaine, G., Wright, V., Greenhalgh, S.
10.1101/2022.05.25.22275599 — Posted: 2022-05-26
SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion
Wang, Q., Guo, Y., Iketani, S., Li, Z., Mohri, H., Wang, M., Yu, J., Bowen, A. D., Chan, J. Y., Shah, J. G., Nguyen, N., Meyers, K., Yin, M. T., Sobieszczyk, M. E., Sheng, Z., Huang, Y., Liu, L., Ho, D.
10.1101/2022.05.26.493517 — Posted: 2022-05-26
Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5
Kimura, I., Yamasoba, D., Tamura, T., Nao, N., Oda, Y., Mitoma, S., Ito, J., Nasser, H., Zahradnik, J., Uriu, K., Fujita, S., Kosugi, Y., Wang, L., Tsuda, M., Kishimoto, M., Ito, H., Suzuki, R., Shimizu, R., Begum, M. M., Yoshimatsu, K., Sasaki, J., Sasaki-Tabata, K., Yamamoto, Y., Nagamoto, T., Kanamune, J., Kobiyama, K., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Kuramochi, J., Schreiber, G., Ishii, K. J., Hashiguchi, T., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ikeda, T., Saito, A., Fukuhara, T., Tanaka, S., Matsuno, K., Sato, K.
10.1101/2022.05.26.493539 — Posted: 2022-05-26
Modelling the impacts of public health interventions and weather on SARS-CoV-2 Omicron outbreak in Hong Kong
Yuan, H.-Y., LIANG, J.
10.1101/2022.05.25.22275487 — Posted: 2022-05-26
Limited induction of lung-resident memory T cell responses against SARS-CoV-2 by mRNA vaccination
Pieren, D. K. J., Kuguel, S. G., Rosado, J., Robles, A. G., Rey-Cano, J., Mancebo, C., Esperalba, J., Falco, V., Buzon, M. J., Genesca, M.
10.1101/2022.05.25.22275300 — Posted: 2022-05-26
Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients
Karaba, A. H., Kim, J., Chiang, T. P.-Y., Alejo, J. L., Abedon, A. T., Mitchell, J., Chang, A., Eby, Y., Johnston, T. S., Aytenfisu, T. Y., Hussey, C., Jefferis, A., Fortune, N., Abedon, R., Thomas, L., Warren, D. S., Sitaras, I., Pekosz, A., Avery, R. K., Massie, A. B., Clarke, W., Tobian, A. A., Segev, D., Werbel, W. A.
10.1101/2022.05.24.22275467 — Posted: 2022-05-26
Overuse in US Medicare during the COVID-19 pandemic
Chalmers, K., Brownlee, S., Gopinath, V., SAINI, V.
10.1101/2022.05.25.22275006 — Posted: 2022-05-26
Health workers Perspective on the Feasibility and Acceptability of the Introduction of AgRDT for COVID-19 in Kisumu County, Western Kenya
Omollo, M. C., Odero, I. A., Barsosio, H. C., Kariuki, S., Kuile, F. T., Okello, S. O., Oyoo, K., K'Oloo, A., Duijn, S. V., Houben, N., Milimo, E., Aroka, R., Odhiambo, A., Onsongo, S. N., Rinke de Wit, T. F.
10.1101/2022.05.24.22275498 — Posted: 2022-05-25
Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs
Reese, J., Blau, H., Bergquist, T., Loomba, J. J., Callahan, T., Laraway, B., Antonescu, C., Casiraghi, E., Coleman, B., Gargano, M., Wilkins, K., Cappelletti, L., Fontana, T., Ammar, N., Antony, B., Murali, T. M., Karlebach, G., McMurry, J. A., Williams, A., Moffitt, R., Banerjee, J., Solomonides, A. E., Davis, H., Kostka, K., Valentini, G., Sahner, D., Chute, C. G., Madlock-Brown, C., Haendel, M. A., Robinson, P. N.
10.1101/2022.05.24.22275398 — Posted: 2022-05-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).